Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Format: Artigo
Jezik:Inglês
Izdano: BMC 2020-11-01
Serija:Cell & Bioscience
Teme:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
Online pristup:http://link.springer.com/article/10.1186/s13578-020-00492-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items